
-
2010
Company Description
Confluence Pharmaceuticals is developing novel therapeutic medications for neurological development disorders
Confluence Pharmaceuticals is developing novel therapeutic medications for neurological development disorders. The company's current focus is advancing a novel drug discovery that improves social and communication impairments for individuals with Autism Spectrum Disorders and Fragile X Syndrome.
-
Manufacturer:
Science and Engineering -
Formed:
2010 -
Founders:
Steven L. Johns -
Company Website:
-
Company E-mail:
-
Company Address:
351 West 10th Street, Box 528Indianapolis, INUnited States -
CEO:
- Steven L. Johns
-
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits